Report Code: A02422 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Tinea pedis is a foot infection caused by dermatophyte fungus such as Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, and can spread to toenails and hands. These fungi thrive in warm, humid conditions and are transmitted through direct contact with an infected person. Tinea pedis is more commonly found in tropic and subtropical countries. Some of the clinical symptoms of tinea pedis are maceration, visible fissuring, and scaling in the interdigital areas of hands and feet. Tinea pedis can be treated using topical antifungals in mildly infected cases; whereas in severe cases require oral antifungal treatments.
The global tinea pedis treatment market is segmented based on disease type, route of administration, distribution channel, and geography. Based on disease type, it is classified into interdigital tinea pedis, plantar tinea pedis, and vesicular tinea pedis. Based on route of administration, the market is bifurcated into oral and topical. Topical segment is further classified into gel, creams, spray, lotions, and powders. Based on distribution channel, it is categorized into hospital pharmacies, retail pharmacies, and e-commerce. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The increase in the incidence rate of infectious diseases caused by bacteria, virus, and fungus have enhanced the R&D activities for the treatment of tinea pedis, which predominantly drive the growth of the tinea pedis treatment market. The rise in the geriatric population and increase in the number of immunocompromised patients has increased the incidence of tinea pedis, which fuels demand for their treatments. However, the stringent approval process hamper the market growth.
Comprehensive competitive analysis and profiles of major market players such as Zimmer Biomet, Depuy Synthes (Johnson & Johnson), Smith & Nephew, Djo (Encore), Zirkonzahn, Waldemar Link, Dragonbio, Stryker, Aesculap (B. Braun), and United Orthopedic Corporation are also provided in this report.
Key Benefits
Tinea Pedis Treatment Market Report Highlights
Aspects | Details |
---|---|
By Disease Type |
|
By Route of Administration |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Zimmer Biomet, Stryker, GlaxoSmithKline PLC, Smith & Nephew, Djo (Encore), Dragonbio, Zirkonzahn, United Orthopedic Corporation, Aesculap (B. Braun), Waldemar Link |
Loading Table Of Content...
Start reading.
This Report and over 71,215+ more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
15%
Discount
15%
Discount
Enterprise
License/PDF
20%
Discount
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers